Abstract:Objective The investigation aimed at producing transgenic mouse model with myocardium-specific overex-pression of human KCNE4 (hKCNE4) gene so as to research into the prophylactic and therapeutic effect of hKCNE4 gene on a certain subset of atrial fibrillation. Methods hKCNE 4 gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR), digested with restrictive endonuclease, and inserted into the cardiomyocyte-specific expressing plasmidα-MHC-Clone 26 by ligase. Enzymatic and sequencing analyses were performed to confirm hKCNE4-α-MHC-Clone 26 prior to obtaining the BamHI treated transgenic element hKCNE4-α-MHC-hGH pA. The hKCNE4-α-MHC-hGH pA was microinjected into the male pronucleus of fertilized oocyte of C57BL mice and the oocytes surviving microin-jection were transplanted into the oviducts of pseudo-pregnant mice. The positive transgenic founder (G0 generation) mice were identified by PCR from offspring generated by pseudo-pregnant mice. The G0 transgenic mice were mated respectively with wild-type C57BL mice to reproduce G1 transgenic progeny. RT-PCR and sequencing were applied to screening for transgenic mice expressing hKCNE4 from G1 transgenic descendants. Results hKCNE4 gene was cloned and ligated to the vectorα-MHC-Clone 26 correctly. 86 mice were generated 9 of which were identified to be transgenic and the trans-gene hKCNE 4 carried by 2 transgenic mice (titled as Line A and Line B respectively) was not only transmitted to the next generation but also overexpressed restrictedly in the hearts. Preliminary phenotypic analysis on the transgenic progeny of Line A and Line B showed that they developed normally, reproduced generally, and suffered from no arrhythmia documented by surface electrocardiography. Conclusion The results indicate that the transgenic mice cardiomyocyte-specifically overexpressing hKCNE 4 are successfully procured, which provides a valuable tool for the exploration of the preventive and remedial influence of hKCNE 4 on a subgroup of atrial fibrillation.

Transgenic mice for cre-inducible overexpression of the Cul4A gene.

Lung tumourigenesis in a conditional Cul4A transgenic mouse model.

Accelerated Hepatocellular Carcinoma Development in CUL4B Transgenic Mice

Knockdown of Cul4A Increases Chemosensitivity to Gemcitabine Through Upregulation of TGFBI in Lung Cancer Cells

Generation and Characterization of Transgenic Mice Expressing Tamoxifen-Inducible Cre-Fusion Protein Specifically in Mouse Liver.

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Generation of a Transgenic Mouse Model with Chondrocyte-Specific and Tamoxifen-Inducible Expression of Cre Recombinase.

Transgenic Mice That Express Cre Recombinasein Hypertrophic Chondrocytes

Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination

Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene

Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation

Expression of Cre Recombinase in an Enhancer-Cre Transgenic Mouse

A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon

Construction and Tissue Specific Expression of Cre Transgenic Mice

The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis

Generation of conditional tetracycline-regulated transgenic mice overexpressing mLAIR-1

Transgenic mice with hematopoietic and lymphoid specific expression of Cre

Conditional and inducible gene recombineering in the mouse inner ear.

Conditional gene targeting in mouse high endothelial venules

Inducible Cre Recombinase Activity In Mouse Cerebellar Granule Cell Precursors And Inner Ear Hair Cells

The Construction of a Cre Recombinase Expression Vector That Targets the Expression of Cre in Pancreas of Transgenic Mouse